MGMT and glioblastoma: Epigenetic studies have revealed that promoting methylation by silencing the MGMT gene is correlated to longer overall survival (OS) in GBM patients after receiving alkylating chemotherapy with carmustine or temozolomide during radiotherapy treatment.4, 5